Search Legislation

Directive 2002/98/EC of the European Parliament and of the CouncilShow full title

Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Changes over time for: Directive 2002/98/EC of the European Parliament and of the Council (Annexes only)

 Help about opening options

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

ANNEX IU.K.INFORMATION TO BE PROVIDED BY BLOOD ESTABLISHMENT TO THE COMPETENT AUTHORITY FOR THE PURPOSES OF DESIGNATION, AUTHORISATION, ACCREDITATION OR LICENSING IN ACCORDANCE WITH ARTICLE 5(2)

Part A:U.K.General information:

  • identification of the blood establishment

  • name, qualification and contact details of responsible persons

  • a list of hospital blood banks which it supplies.

Part B:U.K.A description of the quality system, to include:

  • documentation, such as an organisation chart, including responsibilities of responsible persons and reporting relationships

  • documentation such as site master file or quality manual describing the quality system in accordance with Article 11(1)

  • number and qualifications of personnel

  • hygiene provisions

  • premises and equipment

  • list of standard operating procedures for recruitment, retention and assessment of donors, for processing and testing, distribution and recall of blood and blood components and for the reporting and recording of serious adverse reactions and events.

ANNEX IIU.K.REPORT OF THE BLOOD ESTABLISHMENT'S PRECEDING YEAR'S ACTIVITY

This annual report will include:

  • total number of donors who give blood and blood components

  • total number of donations

  • an updated list of the hospital blood banks which it supplies

  • total number of whole donations not used

  • number of each component produced and distributed

  • incidence and prevalence of transfusion transmissible infectious markers in donors of blood and blood components

  • number of product recalls

  • number of serious adverse events and reactions reported.

ANNEX IIIU.K.LABELLING REQUIREMENTS

The label on the component must contain the following information:

  • the official name of the component

  • the volume or weight or number of cells in the component (as appropriate)

  • the unique numeric or alphanumeric donation identification

  • the name of producing blood establishment

  • the ABO Group (not required for plasma intended only for fractionation)

  • the Rh D Group, either Rh D positive or Rh D negative (not required for plasma intended only for fractionation)

  • the date or time of expiry (as appropriate)

  • the temperature of storage

  • the name, composition and volume of anticoagulant and/or additive solution (if any).

ANNEX IVU.K.BASIC TESTING REQUIREMENTS FOR WHOLE BLOOD AND PLASMA DONATIONS

The following tests must be performed for whole blood and apheresis donations, including autologous predeposit donations:

  • ABO Group (not required for plasma intended only for fractionation)

  • Rh D Group (not required for plasma intended only for fractionation)

  • testing for the following infections in the donors:

    • Hepatitis B (HBs-Ag)

    • Hepatitis C (Anti-HCV)

    • HIV 1/2 (Anti-HIV 1/2)

Additional tests may be required for specific components or donors or epidemiological situations.

Back to top

Options/Help